Breaking News

Cobra Biologics in Manufacturing Pact with University of Sheffield

CDMO’s manufacturing service will scale production of growth hormone developed using ProFuse technology

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cobra Biologics, an international CDMO of biologics and pharmaceuticals, has been appointed by the University of Sheffield to provide a comprehensive manufacturing service for a potential growth hormone (GH) antagonist created using ProFuse Technology originally developed by the University of Sheffield (). This work will allow Sheffield University to progress toxicology trials and prepare for Phase 1 clinical trials, with the help of the Medical Research Council (MRC) (www.mrc.ac.uk): Developmen...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters